Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-12

Clinical Trial Update: Ursodeoxycholic Acid And Cholestasis Of Pregnancy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ursodeoxycholic acid for intrahepatic cholestasis of pregnancy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University of Bologna | Conditions: Intrahepatic Cholestasis of Pregnancy | Phase 3 | Status: WITHDRAWN